We hypothesize that high tumor GPT2 expression contributes to a glutamine-depleted TME, which primarily inhibits the function and infiltration of activated immune cells (leading to a lower overall immune score), while having a lesser impact on naïve cells. The gene discussed is GPT2; the disease is neoplasm.